Laboratorios Farmaceuticos ROVI Stock

Laboratorios Farmaceuticos ROVI Revenue 2024

Laboratorios Farmaceuticos ROVI Revenue

816.82 M EUR

Ticker

ROVI.MC

ISIN

ES0157261019

WKN

A0M0GQ

In 2024, Laboratorios Farmaceuticos ROVI's sales reached 816.82 M EUR, a -1.53% difference from the 829.51 M EUR sales recorded in the previous year.

The Laboratorios Farmaceuticos ROVI Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2028e1.337,93
2027e1.2539,26
2026e1.0845,50
2025e0.954,90
2024e0.8260,27
20230.8359,35
20220.8263,55
20210.6559,32
20200.4257,46
20190.3856,31
20180.357,58
20170.2860,77
20160.2757,75
20150.2560,54
20140.2460,27
20130.2260,98
20120.262,61
20110.1862,43
20100.1660,40
20090.1467,28
20080.1372,31
20070.168,22
20060.1171,81
20050.0871,91
20040.0668,60

Laboratorios Farmaceuticos ROVI Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Laboratorios Farmaceuticos ROVI, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Laboratorios Farmaceuticos ROVI from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Laboratorios Farmaceuticos ROVI’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Laboratorios Farmaceuticos ROVI. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Laboratorios Farmaceuticos ROVI’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Laboratorios Farmaceuticos ROVI’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Laboratorios Farmaceuticos ROVI’s growth potential.

Laboratorios Farmaceuticos ROVI Revenue, EBIT and net profit per share

DateLaboratorios Farmaceuticos ROVI RevenueLaboratorios Farmaceuticos ROVI EBITLaboratorios Farmaceuticos ROVI Net Income
2028e1.3 B undefined463.34 M undefined388.24 M undefined
2027e1.25 B undefined458.67 M undefined333.96 M undefined
2026e1.08 B undefined353.56 M undefined262.04 M undefined
2025e896.72 M undefined259.92 M undefined194.58 M undefined
2024e816.82 M undefined215.51 M undefined160.07 M undefined
2023829.51 M undefined220.25 M undefined170.34 M undefined
2022817.7 M undefined255.85 M undefined199.67 M undefined
2021648.68 M undefined183.07 M undefined153.08 M undefined
2020419.96 M undefined78.77 M undefined61.06 M undefined
2019381.31 M undefined43.18 M undefined39.27 M undefined
2018303.2 M undefined17.46 M undefined17.9 M undefined
2017275.65 M undefined19.01 M undefined17.24 M undefined
2016265.17 M undefined28.3 M undefined26.09 M undefined
2015246.01 M undefined21.84 M undefined19.81 M undefined
2014238.05 M undefined27.43 M undefined24.12 M undefined
2013217.6 M undefined25.4 M undefined23 M undefined
2012201.9 M undefined21.7 M undefined19.5 M undefined
2011184.7 M undefined19 M undefined18.1 M undefined
2010158.6 M undefined26 M undefined24.6 M undefined
2009141.8 M undefined25.5 M undefined20.1 M undefined
2008127.5 M undefined28.3 M undefined23.5 M undefined
2007100.7 M undefined18.4 M undefined15 M undefined
2006105 M undefined13.4 M undefined10.9 M undefined
200582.6 M undefined3.3 M undefined4.1 M undefined
200463.7 M undefined3.5 M undefined14.5 M undefined

Laboratorios Farmaceuticos ROVI stock margins

The Laboratorios Farmaceuticos ROVI margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Laboratorios Farmaceuticos ROVI. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Laboratorios Farmaceuticos ROVI.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Laboratorios Farmaceuticos ROVI's sales revenue. A higher gross margin percentage indicates that the Laboratorios Farmaceuticos ROVI retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Laboratorios Farmaceuticos ROVI's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Laboratorios Farmaceuticos ROVI's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Laboratorios Farmaceuticos ROVI's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Laboratorios Farmaceuticos ROVI. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Laboratorios Farmaceuticos ROVI's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Laboratorios Farmaceuticos ROVI Margin History

Laboratorios Farmaceuticos ROVI Gross marginLaboratorios Farmaceuticos ROVI Profit marginLaboratorios Farmaceuticos ROVI EBIT marginLaboratorios Farmaceuticos ROVI Profit margin
2028e59.35 %35.7 %29.91 %
2027e59.35 %36.58 %26.63 %
2026e59.35 %32.68 %24.22 %
2025e59.35 %28.99 %21.7 %
2024e59.35 %26.38 %19.6 %
202359.35 %26.55 %20.53 %
202263.55 %31.29 %24.42 %
202159.32 %28.22 %23.6 %
202057.46 %18.76 %14.54 %
201956.31 %11.33 %10.3 %
201857.58 %5.76 %5.9 %
201760.77 %6.9 %6.25 %
201657.75 %10.67 %9.84 %
201560.54 %8.88 %8.05 %
201460.27 %11.52 %10.13 %
201360.98 %11.67 %10.57 %
201262.61 %10.75 %9.66 %
201162.43 %10.29 %9.8 %
201060.4 %16.39 %15.51 %
200967.28 %17.98 %14.17 %
200872.31 %22.2 %18.43 %
200768.22 %18.27 %14.9 %
200671.81 %12.76 %10.38 %
200571.91 %4 %4.96 %
200468.6 %5.49 %22.76 %

Laboratorios Farmaceuticos ROVI Aktienanalyse

What does Laboratorios Farmaceuticos ROVI do?

Laboratorios Farmaceuticos ROVI SA is a Spanish pharmaceutical company that was founded in 1946 by Salvador and Ignacio Ruiz-Salmones. The company is headquartered in Madrid and employs over 1,000 employees. ROVI manufactures a variety of pharmaceutical products and offers services in various areas. The company specializes in the development and manufacturing of specialty preparations in the fields of oncology, hematology, endocrinology, and gastroenterology. The company operates in three business areas: specialty pharmaceuticals, contrast agents, and active ingredients for the industry. The specialty pharmaceuticals business area includes medications for various applications, such as the treatment of cancer, blood disorders, endocrine disorders, gastroenterological disorders, and central nervous system disorders. The contrast agents division produces products for radiology and diagnostics. The products are used in various medical fields, from cardiology to gastroenterology. In the active ingredients for the industry business area, ROVI manufactures active ingredients for other pharmaceutical companies. ROVI specializes in the production of specialty products and relies on collaborations with other companies. The company has strategic partnerships with many companies such as GlaxoSmithKline, Pfizer, Sanofi-Aventis, and Zeltia. This also includes some research collaborations to develop and market products together. The company is also dedicated to the development of biosimilars, which allow for the offering of biologic drugs at a lower price. Biosimilars are copies of biopharmaceuticals that are usually very expensive due to the complex manufacturing process and high development costs. ROVI is also a major producer of vaccines that are distributed worldwide. ROVI has followed a solid growth trajectory in recent years. The company has been able to consistently increase its revenue and profit and is now a major player in the pharmaceutical industry. The company also operates a strong research and development department that constantly develops new products and technologies to improve patient care. In summary, Laboratorios Farmaceuticos ROVI SA is a leading pharmaceutical company specializing in the manufacturing of specialty products. With its subsidiaries in Europe and the USA, ROVI has an international presence and has made a name for itself through its expertise in the development and manufacturing of innovative pharmaceutical products. Laboratorios Farmaceuticos ROVI ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Laboratorios Farmaceuticos ROVI's Sales Figures

The sales figures of Laboratorios Farmaceuticos ROVI originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Laboratorios Farmaceuticos ROVI’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Laboratorios Farmaceuticos ROVI's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Laboratorios Farmaceuticos ROVI’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Laboratorios Farmaceuticos ROVI stock

How much revenue did Laboratorios Farmaceuticos ROVI generate this year?

Laboratorios Farmaceuticos ROVI has achieved a revenue of 816.82 M EUR this year.

How much was the turnover of the company Laboratorios Farmaceuticos ROVI compared to the previous year?

The revenue of Laboratorios Farmaceuticos ROVI has increased by -1.53% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Laboratorios Farmaceuticos ROVI?

The revenue of Laboratorios Farmaceuticos ROVI is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Laboratorios Farmaceuticos ROVI measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Laboratorios Farmaceuticos ROVI so important for investors?

The revenue of Laboratorios Farmaceuticos ROVI is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Laboratorios Farmaceuticos ROVI pay?

Over the past 12 months, Laboratorios Farmaceuticos ROVI paid a dividend of 1.29 EUR . This corresponds to a dividend yield of about 1.74 %. For the coming 12 months, Laboratorios Farmaceuticos ROVI is expected to pay a dividend of 1.69 EUR.

What is the dividend yield of Laboratorios Farmaceuticos ROVI?

The current dividend yield of Laboratorios Farmaceuticos ROVI is 1.74 %.

When does Laboratorios Farmaceuticos ROVI pay dividends?

Laboratorios Farmaceuticos ROVI pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Laboratorios Farmaceuticos ROVI?

Laboratorios Farmaceuticos ROVI paid dividends every year for the past 21 years.

What is the dividend of Laboratorios Farmaceuticos ROVI?

For the upcoming 12 months, dividends amounting to 1.69 EUR are expected. This corresponds to a dividend yield of 2.27 %.

In which sector is Laboratorios Farmaceuticos ROVI located?

Laboratorios Farmaceuticos ROVI is assigned to the 'Health' sector.

Wann musste ich die Aktien von Laboratorios Farmaceuticos ROVI kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Laboratorios Farmaceuticos ROVI from 7/10/2024 amounting to 1.104 EUR, you needed to have the stock in your portfolio before the ex-date on 7/8/2024.

When did Laboratorios Farmaceuticos ROVI pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Laboratorios Farmaceuticos ROVI in the year 2023?

In the year 2023, Laboratorios Farmaceuticos ROVI distributed 0.956 EUR as dividends.

In which currency does Laboratorios Farmaceuticos ROVI pay out the dividend?

The dividends of Laboratorios Farmaceuticos ROVI are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Laboratorios Farmaceuticos ROVI

Our stock analysis for Laboratorios Farmaceuticos ROVI Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratorios Farmaceuticos ROVI Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.